Expression of apoptosis-regulating proteins and outcome of esophageal cancer patients treated by combined therapy modalities

Citation
M. Sarbia et al., Expression of apoptosis-regulating proteins and outcome of esophageal cancer patients treated by combined therapy modalities, CLIN CANC R, 4(12), 1998, pp. 2991-2997
Citations number
34
Categorie Soggetti
Oncology
Journal title
CLINICAL CANCER RESEARCH
ISSN journal
10780432 → ACNP
Volume
4
Issue
12
Year of publication
1998
Pages
2991 - 2997
Database
ISI
SICI code
1078-0432(199812)4:12<2991:EOAPAO>2.0.ZU;2-N
Abstract
The present study retrospectively examines the correlation between the outc ome of patients with locally advanced esophageal squamous cell carcinoma (L AEC) after multimodal treatment (radiochemotherapy +/- surgery) and the exp ression of apoptosis-regulating proteins in pretherapeutic biopsies. Thirty-eight patients with LAEC who took part in a prospective multicentric trial received radiochemotherapy, optionally followed by surgery. Pretreat ment tumor biopsies were immunohistochemically investigated for expression of p53, Bcl-2, Bar (bcl-2-associated X protein), and Bcl-X-L (bcl-2-related X protein), The overall expression of p53, Bcl-2, Bar, and Bcl-X-L was 52.6, 57.9, 100, and 97.4% respectively, Tumors without p53 expression and tumors with weak Bcl-X-L expression showed response to chemotherapy more frequently (55.6 a nd 52.6%, respectively) than tumors positive for p53 expression and tumors with strong Bcl-X-L expression (30.0 and 31.6%, respectively); however, the se differences did not attain statistical significance. No correlations wer e found between the expression of Bcl-2 and Bar and the response to chemoth erapy. In patients treated by radiochemotherapy and surgery, p53-negative t umors showed a significantly better outcome than p53-positive tumors (mean survival, 31.1 months versus 11.3 months; P = 0.0378), Additionally, a more favorable outcome was observed in tumors positive for Bcl-2 (not significa nt), whereas no differences in survival were observed in relation to the ex pression of Bar or Bcl-X-L. No differences in survival were observed in pat ients treated by radiochemotherapy without subsequent resection therapy in relation to the expression of apoptosis-regulating proteins. Immunohistochemical examination of pretherapeutic tumor biopsies for expres sion of apoptosis-regulating proteins may help to identify patients with LA EC who may benefit from multimodal treatment and those who may not.